FDG-PET/CT in the staging of local/regional metastases in breast cancer

被引:53
|
作者
Robertson, Ian J. [1 ]
Hand, Fiona [1 ]
Kell, Malcolm R. [1 ]
机构
[1] Mater Misericordiae Univ Hosp, Eccles Breast Screening Unit, Dublin 7, Ireland
关键词
FDG-PET/CT; Breast cancer; Local/regional metastases; POSITRON-EMISSION-TOMOGRAPHY; LYMPH-NODE BIOPSY; MANAGEMENT; SCAN;
D O I
10.1016/j.breast.2011.07.002
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer is the commonest female malignancy in the Western world and the most reliable predictor for survival is axillary lymph node metastases. Conventional staging techniques employed in breast cancer include mammography, ultrasonography, isotope bone scanning, sentinel lymph node biopsy, axillary lymph node dissection and magnetic resonance imaging. More recently FDG-PET and FDG-PET/CT have been used to complement the above methods. This review assesses the role of FOG-PET/CT in axillary staging ill patients with primary breast cancer. A PubMed search was conducted and all articles containing relevant or new information were included. Relevant studies examined identified that FOG-PET/CT has a sensitivity of 60% and a specificity of 97% in detecting lymphatic metastasis. Although positive axillary FOG-PET/CT is a good predictor of axillary disease and correlates well with SLNB, the relatively poor sensitivity (60%) must be considered for treatment planning. (C) 2011 Elsevier Ltd. All rights reserved.
引用
收藏
页码:491 / 494
页数:4
相关论文
共 50 条
  • [11] Breast cancer: initial workup and staging with FDG PET/CT
    Groheux, David
    Hindie, Elif
    CLINICAL AND TRANSLATIONAL IMAGING, 2021, 9 (03) : 221 - 231
  • [12] 18F-FDG PET/CT for Staging and Restaging of Breast Cancer
    Groheux, David
    Cochet, Alexandre
    Humbert, Olivier
    Alberini, Jean-Louis
    Hindie, Elif
    Mankoff, David
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 : 17S - 26S
  • [13] Clinical significance of FDG-PET/CT at the postoperative surveillance in the breast cancer patients
    Jung, Na Young
    Yoo, Ie Ryung
    Kang, Bong Joo
    Kim, Sung Hun
    Chae, Byung Joo
    Seo, Ye Young
    BREAST CANCER, 2016, 23 (01) : 141 - 148
  • [14] Comparison of FDG-PET/CT and bone scintigraphy for detection of bone metastases in breast cancer
    Hahn, Steffen
    Heusner, Till
    Kuemmel, Sherko
    Koeninger, Angelika
    Nagarajah, James
    Mueller, Stefan
    Boy, Christian
    Forsting, Michael
    Bockisch, Andreas
    Antoch, Gerald
    Stahl, Alexander
    ACTA RADIOLOGICA, 2011, 52 (09) : 1009 - 1014
  • [15] Impact of combined FDG-PET/CT and MRI on the detection of local recurrence and nodal metastases in thyroid cancer
    Hempel, Johann-Martin
    Kloeckner, Roman
    Krick, Sandra
    dos Santos, Daniel Pinto
    Schadmand-Fischer, Simin
    Boessert, Patrick
    Bisdas, Sotirios
    Weber, Matthias M.
    Fottner, Christian
    Musholt, Thomas J.
    Schreckenberger, Mathias
    Miederer, Matthias
    CANCER IMAGING, 2016, 16 : 1 - 9
  • [16] How Useful Are Tumor Markers in Detecting Metastases with FDG-PET/CT during Breast Cancer Surveillance?
    Corso, Giovanni
    Gilardi, Laura
    Girardi, Antonia
    De Scalzi, Alessandra Margherita
    Pagani, Gianmatteo
    Rossi, Elisabetta Maria Cristina
    Montagna, Giacomo
    Veronesi, Paolo
    Pagan, Eleonora
    Bagnardi, Vincenzo
    Grana, Chiara Maria
    ONCOLOGY, 2020, 98 (10) : 714 - 718
  • [17] FDG-PET/CT for the Preoperative Lymph Node Staging of Invasive Bladder Cancer
    Swinnen, Greet
    Maes, Alex
    Pottel, Hans
    Vanneste, Alain
    Billiet, Ignace
    Lesage, Karl
    Werbrouck, Patrick
    EUROPEAN UROLOGY, 2010, 57 (04) : 641 - 647
  • [18] The Effect of FDG-PET/CT on Clinical Prognostic Staging of Breast Cancer Patients being Planned Neoadjuvant Treatment
    Simsek, Eda Tanrikulu
    Coban, Ezgi
    Atag, Elif
    Gungor, Serkan
    Aker, Fugen
    Sari, Murat
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2022, 32 (02): : 181 - 185
  • [19] The efficacy of screening with FDG-PET/CT for distant metastases in breast cancer patients scheduled for neoadjuvant systemic therapy
    Gunster, Jetske L. B.
    van Duijnhoven, Frederieke H.
    Scholten, Astrid N.
    Smorenburg, Carolien H.
    Dezentje, Vincent O.
    van Olmen, Josefien P.
    Marijnen, Corrie A. M.
    Stokkel, Marcel P. M.
    Loo, Claudette E.
    Schrijver, A. Marjolein
    BREAST CANCER RESEARCH AND TREATMENT, 2025, 209 (01) : 117 - 124
  • [20] FDG-PET for axillary lymph node staging in primary breast cancer
    Crippa, F
    Gerali, A
    Alessi, A
    Agresti, R
    Bombardieri, E
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2004, 31 (Suppl 1) : S97 - S102